​

Iterum Therapeutics Ownership | Who Owns Iterum Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Iterum Therapeutics Ownership Summary

Iterum Therapeutics is owned by 0.78% insiders, and 99.22% retail investors. Abante Quant Value FI is the top mutual fund, with 0.50% of its assets in Iterum Therapeutics shares.

ITRM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockIterum Therapeutics-0.78%99.22%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20252-50.00%132-99.93%-0.12%--100.00%--
Sep 30, 20253-82,179-6.20%-427.53%2---
Jun 30, 2025350.00%87,61325.14%-519.11%2100.00%--
Mar 31, 20252-50.00%70,01316.60%-229.04%1---
Dec 31, 2024433.33%60,04541310.34%-59157628.57%1-50.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Abante Quant Value FI264.80K0.50%264.80K
AMOne Fisher US Micro Equity Fund35.22K0.16%35.22K
Fidelity Nasdaq Composite Index12.37K0.02%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2025Dunne Michael W.-Buy$2.19K
Aug 08, 2025Dunne Michael W.-Buy$10.85K
Dec 22, 2023Dunne Michael W.-Buy$35.00K
Dec 18, 2023Dunne Michael W.-Buy$18.44K
Nov 22, 2023Dunne Michael W.-Buy$40.69K

Insider Transactions Trends

DateBuySell
2025 Q41-
2025 Q31-
2025 Q1--
2024 Q3--
2023 Q44-

ITRM Ownership FAQ

Who Owns Iterum Therapeutics?

Iterum Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 0.78% insiders and 99.22% retail investors. The average institutional ownership in Iterum Therapeutics's industry, Biotech Stocks , is 382.13%, which Iterum Therapeutics falls below.

Does Blackrock own Iterum Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Iterum Therapeutics.

Who is the top mutual fund holder of Iterum Therapeutics shares?

Abante Quant Value FI is the top mutual fund holder of Iterum Therapeutics shares, with 0.50% of its total shares outstanding invested in 264.8K Iterum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools